Edwards Lifesciences ROA 2010-2024 | EW

Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Edwards Lifesciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-03-31 $1.41B $9.74B 15.09%
2023-12-31 $1.40B $9.36B 15.42%
2023-09-30 $1.43B $9.37B 16.21%
2023-06-30 $1.39B $9.00B 16.08%
2023-03-31 $1.49B $8.65B 17.51%
2022-12-31 $1.52B $8.29B 18.02%
2022-09-30 $1.46B $8.64B 17.17%
2022-06-30 $1.46B $8.43B 17.37%
2022-03-31 $1.54B $8.42B 18.80%
2021-12-31 $1.50B $8.50B 19.06%
2021-09-30 $1.48B $8.16B 19.53%
2021-06-30 $1.46B $7.66B 20.24%
2021-03-31 $0.85B $7.21B 12.30%
2020-12-31 $0.82B $7.24B 12.42%
2020-09-30 $0.79B $6.80B 12.32%
2020-06-30 $0.74B $6.42B 11.93%
2020-03-31 $1.11B $6.08B 18.39%
2019-12-31 $1.05B $6.49B 17.82%
2019-09-30 $0.77B $5.97B 13.86%
2019-06-30 $0.73B $5.57B 12.99%
2019-03-31 $0.77B $5.47B 13.66%
2018-12-31 $0.72B $5.32B 12.69%
2018-09-30 $0.71B $5.96B 12.33%
2018-06-30 $0.66B $5.69B 11.59%
2018-03-31 $0.56B $5.83B 10.13%
2017-12-31 $0.58B $5.67B 11.07%
2017-09-30 $0.75B $5.49B 14.96%
2017-06-30 $0.72B $5.14B 15.26%
2017-03-31 $0.66B $4.78B 14.86%
2016-12-31 $0.57B $4.51B 13.61%
2016-09-30 $0.55B $4.34B 13.55%
2016-06-30 $0.53B $4.05B 13.36%
2016-03-31 $0.52B $3.85B 13.38%
2015-12-31 $0.50B $4.06B 13.17%
2015-09-30 $0.46B $3.88B 12.78%
2015-06-30 $0.44B $3.61B 12.60%
2015-03-31 $0.87B $3.49B 25.54%
2014-12-31 $0.81B $3.52B 25.24%
2014-09-30 $0.78B $3.35B 25.82%
2014-06-30 $0.76B $3.33B 27.06%
2014-03-31 $0.31B $2.65B 11.92%
2013-12-31 $0.39B $2.71B 15.75%
2013-09-30 $0.40B $2.53B 17.17%
2013-06-30 $0.40B $2.34B 17.45%
2013-03-31 $0.37B $2.30B 16.84%
2012-12-31 $0.29B $2.22B 13.70%
2012-09-30 $0.27B $2.20B 12.84%
2012-06-30 $0.25B $2.08B 12.33%
2012-03-31 $0.24B $2.00B 11.94%
2011-12-31 $0.24B $1.98B 12.00%
2011-09-30 $0.24B $1.98B 12.44%
2011-06-30 $0.24B $2.00B 12.66%
2011-03-31 $0.24B $1.93B 13.31%
2010-12-31 $0.22B $1.77B 13.00%
2010-09-30 $0.20B $1.73B 12.27%
2010-06-30 $0.23B $1.64B 14.11%
2010-03-31 $0.22B $1.60B 13.87%
2009-12-31 $0.23B $1.62B 15.29%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $53.535B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.696B 25.77
Intuitive Surgical (ISRG) United States $153.425B 92.43
DexCom (DXCM) United States $46.159B 69.92
Alcon (ALC) Switzerland $44.103B 31.60
IDEXX Laboratories (IDXX) United States $40.960B 48.01
IQVIA Holdings (IQV) United States $39.025B 22.64
STERIS (STE) Ireland $21.680B 25.32
SONOVA HOLDING (SONVY) Switzerland $18.305B 0.00
Waters (WAT) United States $17.203B 25.28
Hologic (HOLX) United States $16.852B 18.85
Fresenius Medical Care AG KGaA (FMS) Germany $11.467B 13.38
Sysmex ADR (SSMXY) Japan $9.736B 30.53
Teleflex (TFX) United States $9.518B 14.81
Globus Medical (GMED) United States $9.070B 26.59
Masimo (MASI) United States $6.934B 39.88
Penumbra (PEN) United States $6.801B 77.29
Glaukos (GKOS) United States $5.624B 0.00
TransMedics (TMDX) United States $4.743B 450.00
Integer Holdings (ITGR) United States $3.878B 23.43
PROCEPT BioRobotics (PRCT) United States $3.093B 0.00
LivaNova (LIVN) United Kingdom $3.012B 17.89
Tandem Diabetes Care (TNDM) United States $2.750B 0.00
Inari Medical (NARI) United States $2.684B 0.00
Nihon Kohden (NHNKY) Japan $2.654B 14.06
Elekta AB (EKTAY) Sweden $2.388B 18.31
Integra LifeSciences Holdings (IART) United States $2.276B 9.92
RxSight (RXST) United States $2.070B 0.00
Veracyte (VCYT) United States $1.664B 0.00
Alphatec Holdings (ATEC) United States $1.434B 0.00
Silk Road Medical (SILK) United States $1.063B 0.00
Artivion (AORT) United States $0.963B 92.40
AVANOS MEDICAL, INC (AVNS) United States $0.893B 17.37
OPKO Health (OPK) United States $0.864B 0.00
OrthoPediatrics (KIDS) United States $0.697B 0.00
Pulse Biosciences (PLSE) United States $0.614B 0.00
IRadimed (IRMD) United States $0.539B 30.16
SiBone (SIBN) United States $0.503B 0.00
Mesa Laboratories (MLAB) United States $0.495B 14.67
ORTHOFIX MEDICAL INC (OFIX) United States $0.477B 0.00
Paragon 28 (FNA) United States $0.476B 0.00
Pacific Biosciences Of California (PACB) United States $0.428B 0.00
Treace Medical Concepts (TMCI) United States $0.363B 0.00
Sight Sciences (SGHT) United States $0.316B 0.00
Nevro (NVRO) United States $0.316B 0.00
AxoGen (AXGN) United States $0.298B 0.00
Tactile Systems Technology (TCMD) United States $0.264B 9.05
Semler Scientific (SMLR) United States $0.249B 12.63
CVRx (CVRX) United States $0.240B 0.00
AngioDynamics (ANGO) United States $0.237B 0.00
Delcath Systems (DCTH) United States $0.226B 0.00
EDAP TMS S.A (EDAP) France $0.196B 0.00
NeuroPace (NPCE) United States $0.190B 0.00
Inogen (INGN) United States $0.185B 0.00
908 Devices (MASS) United States $0.182B 0.00
Accuray (ARAY) United States $0.182B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
ClearPoint Neuro (CLPT) United States $0.152B 0.00
Atossa Genetics (ATOS) United States $0.140B 0.00
Yubo Biotech (YBGJ) China $0.132B 0.00
KORU Medical Systems (KRMD) United States $0.108B 0.00
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
Sensus Healthcare (SRTS) United States $0.085B 17.90
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Hyperfine (HYPR) United States $0.059B 0.00
SEP Acquisition (SEPA) United States $0.056B 0.00
Neuronetics (STIM) United States $0.054B 0.00
T2 Biosystems (TTOO) United States $0.051B 0.00
LENSAR (LNSR) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.036B 0.00
Precision Optics (POCI) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.036B 0.00
Vicarious Surgical (RBOT) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.021B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.018B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
PAVmed (PAVM) United States $0.008B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00